The significance of cerebral GFAP and S100B levels should be discussed according to the context [68]; here, considering situations involved with brain damage, all of the compounds tested showed a similar profile, suggesting astrocytic dysfunction, as found in neurodegenerative diseases. Here, S100B is linked to neurodegenerative disease.